DUALITY BIOTHERAPEUTICS, INC. - B
(HKEX: 9606)
Duality Biotherapeutics, Inc. operates as a clinical stage company. It focuses on the development of next generation antibody-drug conjugate therapeutics and duality immune toxin antibody conjugate therapeutic. The company was founded by Zhu Zhong Yuan on July 3, 2019 and is headquartered in Shanghai, China.
246.000 -
-11.200
(-4.35%)
Range
243.800 - 270.000
(10.75%)
Open
265.000
Previous Close
257.200
Bid Price
245.800
Bid Volume
('000)
0.6
Ask Price
246.000
Ask Volume
('000)
0.3
Volume
('000)
1,397.3
Value
350,084,811
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
